Find your way.

A neuroscientist turned biotech strategy expert with deep experience navigating complex challenges in global markets, Joseph combines scientific and entrepreneurial skillsets to perform rigorous analysis and deliver critical insights to biopharma, diagnostics, and medical device leaders. Joseph supports a range of clients across therapeutic areas and modalities, with particular focus on hematology / oncology, neurology, and rare diseases, developing strategies for pipeline products and portfolios to guide BD, clinical development, and commercialization. An expert on novel technologies, Joseph heads Putnam’s center of excellence on advanced technologies, including cell and gene therapies, requiring sophisticated hospital-based administration and development of new commercialization models. Joseph earned a PhD in Biomedical Engineering from Harvard-MIT, where he specialized in neurophysiology. He also earned a Masters in Mathematics from Cambridge University and graduated magna cum laude from Harvard University with a degree in Physics and Philosophy.

As part of Putnam’s Portfolio, Licensing & Development practice, John helps clients build clinical development and go-to-market strategies. Across therapy areas, he has helped clients drive strategic prioritization decisions about where to position their early-stage assets in the future treatment paradigm, how to determine the target profile and clinical development path required to win and differentiate, and how to size the opportunity and weigh trade-offs. He joined SmartAnalyst (now part of Putnam) in 2003 and has partnered with biopharma clients in North America, Europe, and Asia-Pacific to provide data-driven strategies and insights that inform important clinical development and investment decisions. Prior to SmartAnalyst, he worked in healthcare communications, where he supported media relations for healthcare providers and biotech companies. He graduated summa cum laude from Columbia University.

Lori leads the Medical and Scientific Affairs Practice at Putnam. Her expertise includes multi-stakeholder engagement, center of excellence profiling, organizational design, strategic medical launches, integrated medical evidence ideation, omnichannel strategy, and digital health platforms, including digital therapeutics, AI algorithms, and software as a medical device. Lori has experience in rare diseases including Duchenne muscular dystrophy, hemophilia, growth hormone deficiency, cardiac amyloidosis, acromegaly, sickle cell disease, and primary hyperoxaluria as well as oncology, infectious disease, cardiology, critical care, neurology, and endocrinology. Prior to Putnam, Lori had a Medical Affairs strategy consultancy, built the Medical Affairs division at CDM and later became President. Earlier in her career she gained experience in medical education and MSL training at Bayer, and clinical research at the University of Minnesota. Lori holds an RPh from the University of Iowa, a PharmD from the University of Minnesota, and completed a postdoctoral fellowship in critical care and infectious diseases at the University of Minnesota.

Experienced leader that is passionate about bringing life changing therapies to patients in need.

Amanpreet joined Putnam in July 2021 and is responsible for leading a team of data scientists and engineers in India. With more than 13 years of experience in implementing data led solutions in various industries. His core focus is to enhance healthcare consulting with data science technologies and increase the value proposition. As part of his role, Aman is also responsible to build a large scale, sustainable data platform. Prior to joining Putnam, he has played multiple roles in data science and machine learning consulting, and more recently is working on credit scoring platforms in India. He has a Computer Science Engineering degree and a Master’s in Information Systems.

Jo Ann Saitta, Partner and Global Data Strategy, Analytics, and AI Practice Lead, brings over 20 years of executive experience in healthcare, driving digital transformation and data-led innovation. She helps clients harness the power of data, analytics, and AI to solve complex challenges and achieve sustainable growth, with expertise spanning AI/GenAI programs, data productization, and digital health innovation.

Previously, Jo Ann served as Managing Director at Ernst & Young and Chief Digital Officer at Omnicom Health Group. She holds a master’s in computer science from NJIT and dual bachelor’s degrees from Rutgers University. A strong advocate for women’s health, she currently chairs the Northern New Jersey American Heart Association Board of Directors.